Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Illinois Wellness Insider.
Press releases published on August 18, 2025
Gateway Foundation Welcomes Maria Bruni, Ph.D., As Chief Strategy Officer
EIN Presswire
·
August 18, 2025
Newly created role will support growth, expanding access and strengthening Gateway Foundation’s mission to save lives CHICAGO, IL, UNITED STATES, August 18, 2025 /EINPresswire.com/ -- Gateway Foundation today announced the appointment of Maria Bruni, Ph …
RecoverRx Performance Physical Therapy Now Offering Shockwave Therapy for Faster Recovery and Pain Relief
EIN Presswire
·
August 18, 2025
OAKBROOK TERRACE , IL, UNITED STATES, August 18, 2025 /EINPresswire.com/ -- RecoverRx Performance Physical Therapy, a leading provider of physical therapy, is excited to announce the addition of shockwave therapy to its range of advanced treatment …
Investigation Launched into PFAS Contamination in Illinois; Tamari Law Group Offering Free Education for Communities
EIN Presswire
·
August 18, 2025
CHICAGO, IL, UNITED STATES, August 18, 2025 /EINPresswire.com/ -- Illinois attorney Walid Tamari today announced the launch of an investigation into the impact of per- and polyfluoroalkyl substances (PFAS) — toxic “forever chemicals” — contaminating …
Imbibe Expands Taste Modulation Platform
EIN Presswire
·
August 18, 2025
Solve Formulation Challenges Across Beverage Categories NILES, IL, UNITED STATES, August 18, 2025 /EINPresswire.com/ -- Imbibe, a leading flavor supplier with deep product development expertise, is proud to introduce an expanded SweetSense® line as part …
2025 UNITY in Public Health Research Conference Showcases Student-Led Innovation in the Fight Against Misinformation
EIN Presswire
·
August 18, 2025
Project UNITY’s 2025 conference brought together 220+ leaders and students to present actionable, equity-driven solutions for today’s health crises. CHICAGO, IL, UNITED STATES, August 18, 2025 /EINPresswire.com/ -- The 2025 UNITY in Public Health …
Sienna Announces Offering of $175 Million of 4.112% Series E Senior Unsecured Debentures and Closing of Previously Announced Acquisition in Greater Toronto Area
GlobeNewswire
·
August 18, 2025
NOT FOR DISSEMINATION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MARKHAM, Ontario, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) announced today that it has agreed to issue $175 …
Opthea Provides Corporate Update
GlobeNewswire
·
August 18, 2025
Successful DFA settlement reached Company with cash and cash equivalents of approximately USD20M Dr Fred Guerard, CEO, Tom Reilly, CFO, and Sujal Shah, Director, to step down Dr Jeremy Levin to continue as Chairman and to assume additional responsibilities …
Tevogen CEO Donates Personal Shares to Support Local Law Enforcement
GlobeNewswire
·
August 18, 2025
WARREN, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced that its Founder and CEO, Dr. Ryan Saadi, has donated 10,000 of his personal shares of common stock to the Warren Township …
Tevogen CEO Donates Personal Shares to Support Brain Injury Recovery
GlobeNewswire
·
August 18, 2025
WARREN, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced that Founder and CEO of Tevogen, Dr. Ryan Saadi, donated 10,000 of his personal shares of common stock to the Opportunity …
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 18, 2025
CAMBRIDGE, Mass., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, between August 4, 2025, and August 18, 2025, the Compensation …
Invivyd Announces Continued Neutralizing Activity of PEMGARDA® (pemivibart) and VYD2311 Against Currently Dominant SARS-CoV-2 Variant XFG (“Stratus”)
GlobeNewswire
·
August 18, 2025
New in vitro neutralization data show continued, consistent neutralizing activity of PEMGARDA® (pemivibart) against XFG Centers for Disease Control data and wastewater surveillance data indicate XFG variant appears to be driving a growing wave of COVID-19 …
Eagle Pharmaceuticals Announces 2025 Annual Meeting Date
GlobeNewswire
·
August 18, 2025
WOODCLIFF LAKE, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that its 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”) will be held on October 17, 2025. The …
Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio
GlobeNewswire
·
August 18, 2025
Mowad-Nassar is Senior Vice President at AbbVie and President, Specialty and U.S. Therapeutics Operations Her appointment brings over 30 years of strategic, commercial, and operational expertise in the pharmaceutical and broader healthcare industry, with a …
Precision Optics to Participate in the Lytham Partners 2025 Consumer & Technology Investor Summit on August 19, 2025
GlobeNewswire
·
August 18, 2025
GARDNER, Mass., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that …
Iovance’s Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced Melanoma
GlobeNewswire
·
August 18, 2025
First T cell therapy for a solid tumor cancer and first treatment option approved in Canada for advanced melanoma after anti-PD-1 and targeted therapy SAN CARLOS, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a …
Nyxoah Reports Second Quarter Financial and Operating Results
GlobeNewswire
·
August 18, 2025
REGULATED INFORMATION Nyxoah Reports Second Quarter Financial and Operating Results FDA Approves Genio® System for U.S. Market; Company Begins Commercial Launch Mont-Saint-Guibert, Belgium – August 18, 2025, 10:10pm CET / 4:10 pm ET – Nyxoah SA (Euronext …
Nyxoah Présente ses Résultats Financiers et d’Exploitation pour le Second Trimestre 2025
GlobeNewswire
·
August 18, 2025
INFORMATIONS RÉGLEMENTÉES Nyxoah Présente ses Résultats Financiers et d’Exploitation pour le Second Trimestre 2025 La FDA approuve le système Genio® pour le marché américain ; la Société lance la commercialisation du produit Mont-Saint-Guibert, Belgique – …
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 18, 2025
BRISBANE, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory …
ORIC® Pharmaceuticals Expands Leadership Team with the Appointment of Kevin Brodbeck as Chief Technical Officer
GlobeNewswire
·
August 18, 2025
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …
Scientific Industries to Host Second Quarter Fiscal Year 2025 Financial Results Investor Call on August 20, 2025
GlobeNewswire
·
August 18, 2025
BOHEMIA, N.Y., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a developer of digitally simplified bioprocessing products and vision-based pill counters, announced it will file the Form 10Q and issue a press release on August …